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Tick-borne encephalitis virus (TBEV) is the most impor-
tant arthropod-borne virus in Europe. The Western sub-
type of this pathogenic neurotropic flavivirus is carried by
Ixodes ricinus. Tick-borne encephalitis has become a con-
siderable public health risk in several European countries,
with currently 3000 hospitalized cases per year. The risk
of TBEV-introduction into Belgium remains high and the
presence of infected wildlife in Belgium is suspected.
Domestic animals such as dogs or cattle can serve as
excellent sentinels for TBEV-surveillance in order to
install an early warning surveillance component for this
emerging zoonotic disease of public health importance.
In a targeted, risk-based and cross-sectional sampling
design, serological screening was performed on Belgian cat-
tle (n = 650), selected from the 2010 Belgian national cattle
surveillance serum bank. The three most Eastern provinces
of Belgium, which are geographically situated closest to
known and/or recently emerging TBEV-endemic, were tar-
geted. These areas are also currently known as endemic for
Lyme disease (Borrelia burgdorferi), another disease trans-
mitted by the same tick.
Bovine sera were tested at the TBEV Belgian National
Reference Centre at the WIV-ISP, by gold standard TBEV
seroneutralisation test, based on the rapid fluorescent focus
inhibition test (RFFIT) protocol. Using a conservative >1/
15 cut-off titer for SN test, 17 bovines were seropositive
and six had borderline results (1/10 < titer < 1/15). The
accuracy of the RFFIT-SNT was confirmed in a mouse
inoculation test and by West Nile virus and Rabies virus
serology. There was a positive correlation between the neu-
tralizing antibody titer, determined by SN, and the median
survival time in mice inoculated intranasally with a mix of
virus and serum. Lesions consistent of viral encephalitis
were demonstrated in histopathology.
The overall bovine TBEV-seroprevalence in the targeted
area was estimated between 2.6 and 4.3% and freedom
could no longer be substantiated. Bovines with borderline
results were often located close to confirmed seropositive
animals. The geographical locations roughly coincided
with the known Belgian hot spots for Lyme disease.
This risk-based cross-sectional serological survey in
cattle, obtained through “one health” cooperation con-
firms the presence of infected foci in Belgium for the first
time. Given the relevance of TBEV for the food chain
through consumption of unpasteurized milk and cheese
and through its considerable public health burden in
other European countries, further surveillance in cattle,
other sentinels, ticks and humans at risk is recommended
to further determine the location and size of endemic foci
and the risk for public health.
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